The translational factor eIF3f: The ambivalent eIF3 subunit

Cellular and Molecular Life Sciences

Volumn 70, Issue 19, 2013, Pages 3603-3616

  Marchione, Roberta ^a   Leibovitch, Serge A ^b   Lenormand, Jean Luc ^a  

^a UNIV GRENOBLE ALPES   (France)

^b INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

Apoptosis; Atrophy; Cancer; eIF3f; Hypertrophy

Indexed keywords

CASPASE 3; CDK11 KINASE; CDK11P110 KINASE; CDK11P46 KINASE; EUKARYOTIC INITIATION FACTOR 3F; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR 3; MAMMALIAN TARGET OF RAPAMYCIN; MSS4 INHIBITOR; NOTCH1 RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; PROTEIN KINASE B; RIBOSOME RNA; RNA 18S; RNA 28S; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARABIDOPSIS THALIANA; BIOLOGICAL THERAPY; CAENORHABDITIS ELEGANS; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELLULAR DISTRIBUTION; DROSOPHILA MELANOGASTER; DRUG ACTIVITY; GENE DELETION; GENE DOSAGE; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOSITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; NOMENCLATURE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; RNA DEGRADATION; RNA SYNTHESIS; SCHIZOSACCHAROMYCES POMBE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

EUKARYOTA;

EID: 84884349758     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1263-y     Document Type: Review

References (94)

1. Jackson RJ, Hellen CU, Pestova TV (2010) The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11(2):113-127
2. Pestova TV, Hellen CU (2000) The structure and function of initiation factors in eukaryotic protein synthesis. Cell Mol Life Sci 57(4):651-674
3. Hinnebusch AG (2006) eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci 31(10):553-562
4. Asano K, Kinzy TG, Merrick WC, Hershey JW (1997) Conservation and diversity of eukaryotic translation initiation factor eIF3. J Biol Chem 272(2):1101-1109
5. Asano K, Vornlocher HP, Richter-Cook NJ, Merrick WC, Hinnebusch AG, Hershey JW (1997) Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly. J Biol Chem 272(43):27042-27052
6. Hershey JW, Asano K, Naranda T, Vornlocher HP, Hanachi P, Merrick WC (1996) Conservation and diversity in the structure of translation initiation factor EIF3 from humans and yeast. Biochimie 78(11-12):903-907
7. Browning KS, Gallie DR, Hershey JW, Hinnebusch AG, Maitra U, Merrick WC, Norbury C (2001) Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem Sci 26(5):284
8. Mayeur GL, Fraser CS, Peiretti F, Block KL, Hershey JW (2003) Characterization of eIF3 k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur J Biochem/FEBS 270(20):4133-4139
9. Morris-Desbois C, Rety S, Ferro M, Garin J, Jalinot P (2001) The human protein HSPC021 interacts with Int-6 and is associated with eukaryotic translation initiation factor 3. J Biol Chem 276(49):45988-45995. doi: 10.1074/jbc.M104966200
10. Damoc E, Fraser CS, Zhou M, Videler H, Mayeur GL, Hershey JW, Doudna JA, Robinson CV, Leary JA (2007) Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics 6(7):1135-1146. doi: 10.1074/mcp.M600399-MCP200
11. Sun C, Todorovic A, Querol-Audi J, Bai Y, Villa N, Snyder M, Ashchyan J, Lewis CS, Hartland A, Gradia S, Fraser CS, Doudna JA, Nogales E, Cate JH (2011) Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3). Proc Natll Acad Sci USA 108(51):20473-20478. doi: 10.1073/pnas. 1116821108
12. Benne R, Hershey JW (1976) Purification and characterization of initiation factor IF-E3 from rabbit reticulocytes. Proc Natll Acad Sci USA 73(9):3005-3009
13. Brown-Luedi ML, Meyer LJ, Milburn SC, Yau PM, Corbett S, Hershey JW (1982) Protein synthesis initiation factors from human HeLa cells and rabbit reticulocytes are similar: comparison of protein structure, activities, and immunochemical properties. Biochemistry 21(18):4202-4206
14. Asano K, Phan L, Anderson J, Hinnebusch AG (1998) Complex formation by all five homologues of mammalian translation initiation factor 3 subunits from yeast Saccharomyces cerevisiae. J Biol Chem 273(29):18573-18585
15. Phan L, Zhang X, Asano K, Anderson J, Vornlocher HP, Greenberg JR, Qin J, Hinnebusch AG (1998) Identification of a translation initiation factor 3 (eIF3) core complex, conserved in yeast and mammals, that interacts with eIF5. Mol Cell Biol 18(8):4935-4946
16. Block KL, Vornlocher HP, Hershey JW (1998) Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. J Biol Chem 273(48):31901-31908
17. Valasek L, Phan L, Schoenfeld LW, Valaskova V, Hinnebusch AG (2001) Related eIF3 subunits TIF32 and HCR1 interact with an RNA recognition motif in PRT1 required for eIF3 integrity and ribosome binding. EMBO J 20(4):891-904. doi: 10.1093/emboj/20.4.891
18. Nielsen KH, Valasek L, Sykes C, Jivotovskaya A, Hinnebusch AG (2006) Interaction of the RNP1 motif in PRT1 with HCR1 promotes 40S binding of eukaryotic initiation factor 3 in yeast. Mol Cell Biol 26(8):2984-2998. doi: 10.1128/mcb.26.8.2984-2998.2006
19. Valasek L, Hasek J, Nielsen KH, Hinnebusch AG (2001) Dual function of eIF3j/Hcr1p in processing 20 S pre-rRNA and translation initiation. J Biol Chem 276(46):43351-43360. doi: 10.1074/jbc.M106887200
20. Verlhac MH, Chen RH, Hanachi P, Hershey JW, Derynck R (1997) Identification of partners of TIF34, a component of the yeast eIF3 complex, required for cell proliferation and translation initiation. EMBO J 16(22):6812-6822. doi: 10.1093/emboj/16.22.6812
21. Naranda T, MacMillan SE, Hershey JW (1994) Purified yeast translational initiation factor eIF-3 is an RNA-binding protein complex that contains the PRT1 protein. J Biol Chem 269(51):32286-32292
22. Garcia-Barrio MT, Naranda T, Vazquez de Aldana CR, Cuesta R, Hinnebusch AG, Hershey JW, Tamame M (1995) GCD10, a translational repressor of GCN4, is the RNA-binding subunit of eukaryotic translation initiation factor-3. Genes Dev 9(14):1781-1796
23. Naranda T, MacMillan SE, Donahue TF, Hershey JW (1996) SUI1/p16 is required for the activity of eukaryotic translation initiation factor 3 in Saccharomyces cerevisiae. Mol Cell Biol 16(5):2307-2313
24. Valasek L, Trachsel H, Hasek J, Ruis H (1998) Rpg1, the Saccharomyces cerevisiae homologue of the largest subunit of mammalian translation initiation factor 3, is required for translational activity. J Biol Chem 273(33):21253-21260
25. Vornlocher HP, Hanachi P, Ribeiro S, Hershey JW (1999) A 110-kilodalton subunit of translation initiation factor eIF3 and an associated 135-kilodalton protein are encoded by the Saccharomyces cerevisiae TIF32 and TIF31 genes. J Biol Chem 274(24):16802-16812
26. Danaie P, Wittmer B, Altmann M, Trachsel H (1995) Isolation of a protein complex containing translation initiation factor Prt1 from Saccharomyces cerevisiae. J Biol Chem 270(9):4288-4292
27. Greenberg JR, Phan L, Gu Z, deSilva A, Apolito C, Sherman F, Hinnebusch AG, Goldfarb DS (1998) Nip1p associates with 40 S ribosomes and the Prt1p subunit of eukaryotic initiation factor 3 and is required for efficient translation initiation. J Biol Chem 273(36):23485-23494
28. Hanachi P, Hershey JW, Vornlocher HP (1999) Characterization of the p33 subunit of eukaryotic translation initiation factor-3 from Saccharomyces cerevisiae. J Biol Chem 274(13):8546-8553
29. Naranda T, Kainuma M, MacMillan SE, Hershey JW (1997) The 39-kilodalton subunit of eukaryotic translation initiation factor 3 is essential for the complex's integrity and for cell viability in Saccharomyces cerevisiae. Mol Cell Biol 17(1):145-153
30. Masutani M, Sonenberg N, Yokoyama S, Imataka H (2007) Reconstitution reveals the functional core of mammalian eIF3. EMBO J 26(14):3373-3383. doi: 10.1038/sj.emboj.7601765
31. Pyronnet S, Sonenberg N (2001) Cell-cycle-dependent translational control. Curr Opin Genet Dev 11(1):13-18
32. Kovarik P, Hasek J, Valasek L, Ruis H (1998) RPG1: an essential gene of saccharomyces cerevisiae encoding a 110-kDa protein required for passage through the G1 phase. Curr Genet 33(2):100-109
33. Evans DR, Singer RA, Johnston GC, Wheals AE (1994) Cell-cycle mutations among the collection of Saccharomyces cerevisiae dna mutants. FEMS Microbiol Lett 116(2):147-153
34. Dong Z, Liu Z, Cui P, Pincheira R, Yang Y, Liu J, Zhang JT (2009) Role of eIF3a in regulating cell cycle progression. Exp Cell Res 315(11):1889-1894. doi: 10.1016/j.yexcr.2009.03.009
35. Chudinova EM, Ivanov PA, Nadezhdina ES (2004) Large subunit of translation initiation factor-3 p170 contains potentially functional nuclear localization signals. Mol Biol (Mosk) 38(4):684-691
36. Morris-Desbois C, Bochard V, Reynaud C, Jalinot P (1999) Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. J Cell Sci 112(Pt 19):3331-3342
37. Watkins SJ, Norbury CJ (2004) Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts. Cell Prolif 37(2):149-160
38. Shen X, Yang Y, Liu W, Sun M, Jiang J, Zong H, Gu J (2004) Identification of the p28 subunit of eukaryotic initiation factor 3(eIF3 k) as a new interaction partner of cyclin D3. FEBS Lett 573(1-3):139-146. doi: 10.1016/j.febslet.2004.07.071
39. Shi J, Feng Y, Goulet AC, Vaillancourt RR, Sachs NA, Hershey JW, Nelson MA (2003) The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J Biol Chem 278(7):5062-5071
40. Hershey JW (2010) Regulation of protein synthesis and the role of eIF3 in cancer. Braz J Med Biol Res 43(10):920-930
41. Silvera D, Formenti SC, Schneider RJ (2010) Translational control in cancer. Nat Rev Cancer 10(4):254-266
42. Dong Z, Zhang JT (2006) Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol/Hematol 59(3):169-180. doi: 10.1016/j.critrevonc.2006.03.005
43. Guo J, Hui DJ, Merrick WC, Sen GC (2000) A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 19(24):6891-6899. doi: 10.1093/emboj/19.24.6891
44. Hui DJ, Bhasker CR, Merrick WC, Sen GC (2003) Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 278(41):39477-39482. doi: 10.1074/jbc.M305038200
45. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, Imataka H, Gehring K, Sonenberg N (2008) Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 28(21):6658-6667. doi: 10.1128/mcb.00738-08
46. Lee JP, Brauweiler A, Rudolph M, Hooper JE, Drabkin HA, Gemmill RM (2010) The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res MCR 8(1):93-106. doi: 10.1158/1541-7786.mcr-08-0491
47. Goh SH, Hong SH, Lee BC, Ju MH, Jeong JS, Cho YR, Kim IH, Lee YS (2011) eIF3 m expression influences the regulation of tumorigenesis-related genes in human colon cancer. Oncogene 30(4):398-409. doi: 10.1038/onc.2010.422
48. Zhang L, Pan X, Hershey JW (2007) Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282(8):5790-5800
49. Zhang L, Smit-McBride Z, Pan X, Rheinhardt J, Hershey JW (2008) An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. J Biol Chem 283(35):24047-24060. doi: 10.1074/jbc.M800956200
50. Miyazaki S, Imatani A, Ballard L, Marchetti A, Buttitta F, Albertsen H, Nevanlinna HA, Gallahan D, Callahan R (1997) The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics 46(1):155-158. doi: 10.1006/geno.1997.4996
51. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Callahan R (2001) Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol 18(1):175-179
52. Buttitta F, Martella C, Barassi F, Felicioni L, Salvatore S, Rosini S, D'Antuono T, Chella A, Mucilli F, Sacco R, Mezzetti A, Cuccurullo F, Callahan R, Marchetti A (2005) Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin Cancer Res 11(9):3198-3204. doi: 10.1158/1078-0432.ccr-04-2308
53. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Cunningham JT, Nelson MA, Shi J (2008) Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol Carcinog 47(3):235-244
54. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Leong SP, Nelson MA, Shi J (2008) Loss of the eukaryotic initiation factor 3f in melanoma. Mol Carcinog 47(10):806-813
55. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, Leong SP, Nelson MA (2006) Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 25(35):4923-4936
56. Wen F, Zhou R, Shen A, Choi A, Uribe D, Shi J (2012) The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS ONE 7(3):e34194
57. Valente ST, Gilmartin GM, Mott C, Falkard B, Goff SP (2009) Inhibition of HIV-1 replication by eIF3f. Proc Natll Acad Sci USA 106(11):4071-4078. doi: 10.1073/pnas.0900557106
58. Valente ST, Gilmartin GM, Venkatarama K, Arriagada G, Goff SP (2009) HIV-1 mRNA 3′ end processing is distinctively regulated by eIF3f, CDK11, and splice factor 9G8. Mol Cell 36(2):279-289. doi: 10.1016/j.molcel.2009.10.004
59. Dunand-Sauthier I, Walker C, Wilkinson C, Gordon C, Crane R, Norbury C, Humphrey T (2002) Sum1, a component of the fission yeast eIF3 translation initiation complex, is rapidly relocalized during environmental stress and interacts with components of the 26S proteasome. Mol Biol Cell 13(5):1626-1640
60. Shi J, Hershey JW, Nelson MA (2009) Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett 583(6):971-977
61. Aravind L, Ponting CP (1998) Homologues of 26S proteasome subunits are regulators of transcription and translation. Protein Sci 7(5):1250-1254. doi: 10.1002/pro.5560070521
62. Hofmann K, Bucher P (1998) The PCI domain: a common theme in three multiprotein complexes. Trends Biochem Sci 23(6):204-205
63. Fu H, Reis N, Lee Y, Glickman MH, Vierstra RD (2001) Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J 20(24):7096-7107. doi: 10.1093/emboj/20.24.7096
64. Sanches M, Alves BS, Zanchin NI, Guimaraes BG (2007) The crystal structure of the human Mov34 MPN domain reveals a metal-free dimer. J Mol Biol 370(5):846-855. doi: 10.1016/j.jmb.2007.04.084
65. Zhang H, Gao ZQ, Wang WJ, Liu GF, Shtykova EV, Xu JH, Li LF, Su XD, Dong YH (2012) The crystal structure of the MPN domain from the COP9 signalosome subunit CSN6. FEBS Lett 586(8):1147-1153. doi: 10.1016/j.febslet.2012.03.029
66. Bunnell BA, Heath LS, Adams DE, Lahti JM, Kidd VJ (1990) Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. Proc Natll Acad Sci USA 87(19):7467-7471
67. Loyer P, Trembley JH, Lahti JM, Kidd VJ (1998) The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. J Cell Sci 111(Pt 11):1495-1506
68. Dickinson LA, Edgar AJ, Ehley J, Gottesfeld JM (2002) Cyclin L is an RS domain protein involved in pre-mRNA splicing. J Biol Chem 277(28):25465-25473. doi: 10.1074/jbc.M202266200
69. Xiang J, Lahti JM, Grenet J, Easton J, Kidd VJ (1994) Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. J Biol Chem 269(22):15786-15794
70. Ariza ME, Broome-Powell M, Lahti JM, Kidd VJ, Nelson MA (1999) Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases. J Biol Chem 274(40):28505-28513
71. Beyaert R, Kidd VJ, Cornelis S, Van de Craen M, Denecker G, Lahti JM, Gururajan R, Vandenabeele P, Fiers W (1997) Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J Biol Chem 272(18):11694-11697
72. Paziewska A, Wyrwicz LS, Ostrowski J (2005) The binding activity of yeast RNAs to yeast Hek2p and mammalian hnRNP K proteins, determined using the three-hybrid system. Cell Mol Biol Lett 10(2):227-235
73. Walter BM, Nordhoff C, Varga G, Goncharenko G, Schneider SW, Ludwig S, Wixler V (2012) Mss4 protein is a regulator of stress response and apoptosis. Cell Death Dis 3:e297
74. Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology 23:160-170. doi: 10.1152/physiol.00041.2007
75. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18(16):1926-1945. doi: 10.1101/gad.1212704
76. Teleman AA, Hietakangas V, Sayadian AC, Cohen SM (2008) Nutritional control of protein biosynthetic capacity by insulin via Myc in Drosophila. Cell Metab 7(1):21-32. doi: 10.1016/j.cmet.2007.11.010
77. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3(11):1014-1019. doi: 10.1038/ncb1101-1014
78. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S (2002) A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natll Acad Sci USA 99(14):9213-9218. doi: 10.1073/pnas.142166599
79. Holz MK, Ballif BA, Gygi SP, Blenis J (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123(4):569-580. doi: 10.1016/j.cell.2005.10.024
80. Harris TE, Chi A, Shabanowitz J, Hunt DF, Rhoads RE, Lawrence JC Jr (2006) mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J 25(8):1659-1668. doi: 10.1038/sj.emboj.7601047
81. Csibi A, Tintignac LA, Leibovitch MP, Leibovitch SA (2008) eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy. Cell Cycle 7(12):1698-1701
82. Iadevaia V, Caldarola S, Tino E, Amaldi F, Loreni F (2008) All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5′-terminal oligopyrimidine (TOP) mRNAs. RNA 14(9):1730-1736. doi: 10.1261/rna.1037108
83. Meyuhas O (2000) Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem/FEBS 267(21):6321-6330
84. Avruch J, Lin Y, Long X, Murthy S, Ortiz-Vega S (2005) Recent advances in the regulation of the TOR pathway by insulin and nutrients. Curr Opin Clin Nutr Metab Care 8(1):67-72
85. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485(7396):109-113. doi: 10.1038/nature11083
86. Csibi A, Cornille K, Leibovitch MP, Poupon A, Tintignac LA, Sanchez AM, Leibovitch SA (2010) The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. PLoS ONE 5(2):e8994. doi: 10.1371/journal.pone.0008994
87. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98(25):14440-14445. doi: 10.1073/pnas.251541198
88. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294(5547):1704-1708. doi: 10.1126/science.1065874
89. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, Lecker SH, Goldberg AL (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21(1):140-155. doi: 10.1096/fj.06-6604com
90. Csibi A, Leibovitch MP, Cornille K, Tintignac LA, Leibovitch SA (2009) MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines. J Biol Chem 284(7):4413-4421. doi: 10.1074/jbc.M807641200
91. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, Segura CT, Leibovitch SA (2008) The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 27(8):1266-1276. doi: 10.1038/emboj.2008.52
92. Moretti J, Chastagner P, Gastaldello S, Heuss SF, Dirac AM, Bernards R, Masucci MG, Israel A, Brou C (2010) The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation. PLoS Biol 8(11):e1000545. doi: 10.1371/journal.pbio.1000545
93. Carson JA (1997) The regulation of gene expression in hypertrophying skeletal muscle. Exerc Sport Sci Rev 25:301-320
94. Baar K, Esser K (1999) Phosphorylation of p70(S6 k) correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol 276(1 Pt 1):C120-C127